Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.

Chinoin, Ltd.

Jozsef Lengyel

Tamas Szuts

Katalin Marmarosi

Kalman Magyar

Istvan Hermecz

Katalin Marmarosi Nee Kellner

Peter Szentmiklosi

Jozsef Gaal

Istvan Szatmari

Gabor Kovacs

Agnes Horvath

Sandor Virag

Lelle V Vasvari Nee Debreczy

Andras Szego

Gyula Sebestyen

Gabor Horvath

Peter S Kormoczy

Jeno Marton

Zoltan Torok

Karoly Lapis

Istvan Sziraki

Jozsef Nemes

Janos Pinter

Janos Feher

Maria Hornyak

Jozsef Schawartz

Katalin Kalloy

Anna Z Szabo

Peter Sarkozi

Gabor Szekacs

Erzsebet Babos Nee Vajas

Michael Mezei

Agnes Turi

Geza Kerszturi

Gabriella Szabo Nee Ujhelyi

Szabo Anna Z

Antal Toth

Eniko Schreiner Nee Kovats

Anna Szekely

Gyula Szebeni

Liposome composition containing selegilin

Pharmaceutical composition and process for the preparation thereof

An anhydrous transdermal composition is disclosed comprising in a 20 to 100% lyotropic liquid crystalline arrangement:

Transdermal compositions

This invention relates to a primycin-containing colloidal basic gel comprising 5-30% of primycin and 95-70% of N-methyl-pyrrolidone-2. The invention also relates to antibacterial compositions particularly for the treatment of acne vulgaris comprising as active ingredient 0.1-100% of a primycin-containing colloidal basic gel, if desired together with further antimicrobial active ingredients, in admixture with 99.9-0% of usual inert pharmaceutical filling, diluting and other formulating additives. The invention also relates to combination composition comprising as active ingredient 1-60% of a primycin-containing colloidal basic gel and 0.1-40% of further pharmaceutical active ingredient(s), e.g. one or more antibiotic(s), chemotherapeutical agent(s), fungistatic or fungicidal agent(s), steroidal or non-steroidal antiinflammatory agent (s), epithelogenic agent(s), local anaesthetic(s), and/or vitamin(s).

Primycin-containing colloidal basic gel

N,N,N-trimethyl-2-hydroxyethyl-ammonium-[1-ethyl-6-fluoro-4-oxo-7-(1-pipera zinyl)-1,4-dihydro-quinolizine-3-carboxylate] of the formula I ##STR1## as a norfloxacin antimicrobial salt capable of enteral administration.

Medicinal norfloxacin salts

The present invention relates to synergistic pharmaceutical compositions for the treatment of liver disorders comprising 5-aminoimidazole-4-carboxamide orthophosphate (AICA-phosphate) as active ingredient in association with vitamins, preferably with vitamin B and/or E and optionally with other pharmaceutical excipients.

Synergistic pharmaceutical compositions

Growing community of inventors

Budapest, Hungary

Jozsef Lengyel